Co-Diagnostics Stock

Co-Diagnostics EBITDA per Employee

The EBITDA per Employee of Co-Diagnostics (CODX) as of Aug 6, 2026 is -1.16 M USD. In the previous year, EBITDA per Employee was -1.43 M USD — a change of -19.17% (higher).

EBITDA per Employee

-1.16 MUSD

YoY

-19.17%

Last updated:

EBITDA per Employee of Co-Diagnostics is 2026 -1.16 M USD. EBITDA per Employee of Co-Diagnostics was 2025 -1.43 M USD. It decreases by -19.17% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Co-Diagnostics Stock analysis

What does Co-Diagnostics do? Co-Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Co-Diagnostics stock

EBITDA per Employee of Co-Diagnostics is -1.16 M USD in 2026.

EBITDA per Employee of Co-Diagnostics changed from -1.43 M USD to -1.16 M USD, representing a -19.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Co-Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Co-Diagnostics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Co-Diagnostics

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Co-Diagnostics